Amêndoa de baru reduz a adiposidade abdominal de adultos com diabetes Mellitus tipo 2
um estudo randomizado, placebocontrolado, crossover
Palavras-chave:
Composição corporal, Diabetes Mellitus Tipo 2, Intervenção dietética, Nozes, Manejo da obesidadeResumo
Objetivo
Avaliar o efeito da suplementação com amêndoa de baru sobre a composição corporal e perfil metabólico de adultos com diabetes Mellitus tipo 2.
Métodos
Este é um estudo randomizado, placebo-controlado, crossover com 30 adultos com diabetes Mellitus tipo 2. O ensaio clínico foi dividido em dois períodos de 12 semanas cada, com um washout de 12 semanas entre os tratamentos. Os sujeitos foram randomizados e receberam dois tratamentos em períodos alternativos: suplementação com 30 g de amêndoa de baru ou placebo. Foram coletados dados referentes à antropometria, composição corporal, pressão arterial, amostras de sangue, ingestão de alimentos e práticas de atividade física.
Resultados
A ingestão de amêndoa de baru reduziu a circunferência da cintura (p=0,032), em comparação com o grupo placebo. Na análise intragrupo, a ingestão de amêndoa de baru também reduziu o colesterol total (p=0,012) e LDL-c (p=0,017).
Conclusão
A ingestão diária de amêndoa de baru melhorou a adiposidade abdominal, portanto, deve ser incluída na dieta para a melhora do estado de saúde de adultos com diabetes Mellitus tipo 2.
Referências
Abazarfard Z, Salehi M, Keshavarzi S. The effect of almonds on anthropometric measurements and lipid profile in overweight and obese females in a weight reduction program: A randomized controlled clinical trial. J Res Med Sci. 2014;19(5):457-64.
Rock CL, Flatt SW, Pakiz B, Quintana EL, Heath DD, Rana BK, et al. Effects of diet composition on weight loss, metabolic factors and biomarkers in a 1-year weight loss intervention in obese women examined by baseline insulin resistance status. Metabolism. 2016;65(11):1605-13. https://doi:10.1016/j.metabol.2016.07.008
Cassady BA, Hollis JH, Fulford AD, Considine RV, Mattes RD. Mastication of almonds: effects of lipid bioaccessibility, appetite, and hormone response. Am J Clin Nutr. 2009;89(3):794-800. https://doi:10.3945/ajcn.2008.26669
Ellis PR, Kendall CW, Ren Y, Parker C, Pacy JF, Waldron KW, et al. Role of cell walls in the bioaccessibility of lipids in almond seeds. Am J Clin Nutr. 2004;80(3):604-13. https://doi:10.1093/ajcn/80.3.604
Mattes RD, Dreher ML. Nuts and healthy body weight maintenance mechanisms. Asia Pac J Clin Nutr. 2010;19(1):137-41.
Baer DJ, Gebauer SK, Novotny JÁ. Walnuts Consumed by Healthy Adults Provide Less Available Energy than Predicted by the Atwater Factors. J Nutr. 2016;146(1):9-13. https://doi:10.3945/jn.115.217372
Pasman WJ, Heimerikx J, Rubingh CM, Van Den Berg R, O’Shea M, Gambelli L, et al. The effect of Korean pine nut oil on in vitro CCK release, on appetite sensations and on gut hormones in post-menopausal overweight women. Lipids Health Dis. 2008;20(7):10. https://doi:10.1186/1476-511X-7-10
Reis CE, Ribeiro DN, Costa NM, Bressan J, Alfenas RC, Mattes RD. Acute and second-meal effects of peanuts on glycaemic response and appetite in obese women with high type 2 diabetes risk: a randomised cross-over clinical trial. Br J Nutr. 2013;109(11):2015-23. https://doi:10.1017/S0007114512004217
Jenkins DJ, Kendall CW, Axelsen M, Augustin LS, Vuksan V. Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease. Curr Opin Lipidol. 2000;11:49-56.
Tan SY, Dhillon J, Mattes RD. A review of the effects of nuts on appetite, food intake, metabolism, and body weight. Am J Clin Nutr. 2014;100:412S-422S. https://doi:10.3945/ajcn.113.071456
Budriesi R, Vivarelli F, Canistro D, Aldini R, Babot Marquillas C, Corazza I, et al. Liver and intestinal protective effects of Castanea sativa Mill. bark extract in high-fat diet rats. PLos One. 2018;13(8):e0201540 https://doi:10.1371/journal.pone.0201540
Lei F, Zhang XN, Wang W, Xing DM, Xie WD, Su H, et al. Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice. Int J Obes. 2007;31(6):1023-9. https://doi:10.1038/ sj.ijo.0803502
Bragg F, Tang K, Guo Y, Iona A, Du H, Holmes MV, et al. China Kadoorie Biobank (CKB) Collaborative Group. Associations of General and Central Adiposity with Incident Diabetes in Chinese Men and Women. Diabetes Care. 2018;41(3):494-502. https://doi:10.2337/dc17-1852
Chen P, Hou X, Hu G, Wei L, Jiao L, Wang H, et al. Abdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes? Cardiovasc Diabetol. 2018;26;17(1):93. https://doi:10.1186/s12933-018-0734-8
Stokes A, Preston SH. The contribution of rising adiposity to the increasing prevalence of diabetes in the United States. Prev Med. 2017;101:91-5. https://doi:10.1016/j.ypmed.2017.05.031
Hill JH, Solt C, Foster MT. Obesity associated disease risk: the role of inherent differences and location of adipose depots. Horm Mol Biol Clin Investig. 2018;16;33(2). https://doi:10.1515/hmbci-2018-0012
Huh JY, Park YJ, Ham M, Kim JB. Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells. 2014;37(5):365-71. https://doi:10.14348/molcells.2014.0074
Seijkens T, Kusters P, Chatzigeorgiou A, Chavakis T, Lutgens E. Immune cell crosstalk in obesity: a key role for costimulation? Diabetes. 2014;63(12):3982-91. https://doi:10.2337/db14-0272
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2023 Beatriz Assis Carvalho CRUVINEL, Ana Gabriella Pereira ALVES, Raquel Machado SCHINCAGLIA, Maria Sebastiana SILVA
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
